EAM Investors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,917
Closed -$1.19M 327
2023
Q3
$1.19M Hold
20,917
0.23% 199
2023
Q2
$1.07M Buy
+20,917
New +$1.07M 0.2% 232